Department of Bioengineering and Therapeutic Sciences

Learning how to solve problems and think critically—using course content as the vehicle to apply these skills—is one evolving goal of the UCSF School of Pharmacy doctor of pharmacy (PharmD) curriculum, according to the School’s dean, B. Joseph Guglielmo PharmD, in an interview posted April 12, 2016...

John Urquhart, MD, passed away on March 19, 2016. Urquhart was an adjunct professor in the Department Bioengineering and Therapeutic Sciences at the UCSF School of Pharmacy. He was best known for pioneering the science of medication adherence and for development of innovative electronic...

For the 36th consecutive year, the UCSF School of Pharmacy has received more funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

Researchers in the laboratory of UCSF School of Pharmacy faculty member Nadav Ahituv, PhD, study the roles of gene regulatory elements—DNA segments that tell genes when, where, and to what extent to turn on and off—including in human conditions ranging from limb malformations to epilepsy and autism.

The statutory requirement for substantial evidence of effectiveness of a new drug has generally been interpreted to require demonstration of a low probability (p<0.05), assuming non-effectiveness, based on data from two phase III clinical trials.

UC San Francisco today announced the establishment of the Quantitative Biosciences Institute (QBI).